The context: Psoriasic arthritis lies somewhere between rhumatoid polyarthr
itis and spondyloathropathy. Its prevalence is about 0.1% with a 1/1 sex ra
tio. Mean age at onset of symptoms is 40 years. in 10 to 15% of the cases,
rhumatological manifestations are observed before skin lesions. Ungueal inv
olvement is particularly frequent.
Five clinical forms: Classically, five clinical forms are described: arthri
tis limited to the distal interphalangeal joints, mutilating arthritis, sym
metrical polyarthritis, asymmetrical mono- or oligoarthritis, and spondylit
is. Asymmetrical oligoarticular forms and polyarthrtis predominate.
Disease severity: In general psoriasic arthritis is a benign condition. Sev
ere forms have however been described with erosion and osteolysis involving
the distal inter-phalangeal joints. Typical radiological may be observed.
Therapeutic options: Non-steroidal antiinflammatory drugs help control dise
ase progression in about one-third of the cases. In other patients, gold sa
lts, D-penicillamine, methotrexate, or sulfasalazine may be required.